Aged
Bone Neoplasms
/ pathology
Bone and Bones
/ pathology
Edetic Acid
/ analogs & derivatives
Gallium Isotopes
Gallium Radioisotopes
Humans
Image-Guided Biopsy
/ methods
Male
Middle Aged
Molecular Diagnostic Techniques
Oligopeptides
/ pharmacokinetics
Positron Emission Tomography Computed Tomography
/ methods
Prospective Studies
Prostatic Neoplasms
/ diagnostic imaging
Radiopharmaceuticals
/ pharmacokinetics
68Ga-PSMA-PET
bone biopsy
molecular diagnostics
prostate cancer
whole-genome sequencing
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
27
12
2019
accepted:
09
03
2020
pubmed:
15
3
2020
medline:
10
3
2021
entrez:
15
3
2020
Statut:
ppublish
Résumé
For individual treatment decisions in patients with metastatic prostate cancer (mPC), molecular diagnostics are increasingly used. Bone metastases are frequently the only source for obtaining metastatic tumor tissue. However, the success rate of CT-guided bone biopsies for molecular analyses in mPC patients is approximately only 40%. PET using
Identifiants
pubmed: 32169916
pii: jnumed.119.241109
doi: 10.2967/jnumed.119.241109
doi:
Substances chimiques
Gallium Isotopes
0
Gallium Radioisotopes
0
Oligopeptides
0
Radiopharmaceuticals
0
gallium 68 PSMA-11
0
Edetic Acid
9G34HU7RV0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1607-1614Informations de copyright
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.